# Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

> **NCT02371252** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 140 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Generic alendronate

## Key facts

- **NCT ID:** NCT02371252
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371252, "Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02371252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*